𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti–cyclic citrullinated peptide antibodies in psoriasis patients without arthritis

✍ Scribed by Raik Böckelmann; Harald Gollnick; Bernd Bonnekoh

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
47 KB
Volume
54
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benefit of early treatment in inflammato
Benefit of early treatment in inflammatory polyarthritis patients with anti–cyclic citrullinated peptide antibodies versus those without antibodies
✍ Tracey M. Farragher; Mark Lunt; Darren Plant; Diane K. Bunn; Anne Barton; Debora 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 107 KB 👁 2 views

## Abstract ## Objective To compare the clinical utility of anti–cyclic citrullinated peptide (anti‐CCP) antibodies and rheumatoid factor (RF) testing in predicting both functional outcome and response to treatment in early inflammatory polyarthritis (IP) patients. ## Methods A total of 916 IP s

Association of HLA–DR3 with anti–cyclic
Association of HLA–DR3 with anti–cyclic citrullinated peptide antibody–negative rheumatoid arthritis
✍ Kirsten N. Verpoort; Floris A. van Gaalen; Annette H. M. van der Helm-van Mil; G 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

## Abstract ## Objective Recent data have shown that the most prominent and longest known genetic risk factors for rheumatoid arthritis (RA), HLA–DRB1 shared epitope alleles, are only associated with RA that is characterized by the presence of antibodies against cyclic citrullinated peptide (anti‐